References
- MersmannJLatschKHabeckKZacharowskiKMeasure for measure— determination of infarct size in murine models of myocardial ischemia and reperfusion: a systematic reviewShock201135544945521192281
- ScottRCRosanoJMIvanovZTargeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac functionFASEB J200923103361336719535683
- TakahamaHMinaminoTAsanumaHProlonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in ratsJ Am Coll Cardiol200953870971719232905
- LundyDJChenKHTohEKHsiehPCDistribution of Systemically Administered Nanoparticles Reveals a Size-Dependent Effect Immediately following Cardiac Ischaemia-Reperfusion InjurySci Rep201662561327161857
- KlonerRACurrent state of clinical translation of cardioprotective agents for acute myocardial infarctionCirc Res2013113445146323908332
- ChangMYYangYJChangCHFunctionalized nanoparticles provide early cardioprotection after acute myocardial infarctionJ Control Rel20131702287294
- Seif-NaraghiSBSingelynJMSalvatoreMASafety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarctionSci Transl Med20135173ra125
- FormigaFRPelachoBGarbayoESustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion modelJ Control Rel201014713037
- DalyCKwongRYCardiac MRI for myocardial ischemiaMethodist Debakey Cardiovasc J20139312313124066194
- KimRJAlbertTSWibleJHPerformance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trialCirculation2008117562963718212288
- SaeedMLundGWendlandMFBremerichJWeinmannHHigginsCBMagnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast mediaCirculation2001103687187611171797
- IdéeJMPortMDencausseALancelotECorotCInvolvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an updateRadiol Clin North Am200947585586919744600
- PanDCaruthersSDSenpanASchmiederAHWicklineSALanzaGMRevisiting an old friend: manganese-based MRI contrast agentsWiley Interdiscip Rev Nanomed Nanobiotechnol20113216217320860051
- WolfGLBaumLCardiovascular toxicity and tissue proton T1 response to manganese injection in the dog and rabbitAJR Am J Roentgenol198314111931976305179
- HuangHYueTXuKGolzarianJYuJHuangJFabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticlesColloids Surf B Biointerfaces201513114815425982318
- ChenNShaoCLiSCy5.5 conjugated MnO nanoparticles for magnetic resonance/near-infrared fluorescence dual-modal imaging of brain gliomasJ Colloid Interface Sci2015457273426151564
- ZhengYYZhangHHYanXXProtective effect of low dose gadolinium chloride against isoproterenol-induced myocardial injury in ratApoptosis20152091164117526089194
- National Research CouncilGuide for the Care and Use of Laboratory Animals8th edWashington, DCNational Academies Press2011
- ChenMZhengYYSongYTPretreatment with low-dose gadolinium chloride attenuates myocardial ischemia/reperfusion injury in ratsActa Pharmacol Sin201637445346226948086
- PengYKLaiCWLiuCLA new and facile method to prepare uniform hollow MnO/functionalized mSiO2 core/shell nanocompositesACS Nano2011554177418721548648
- TomaIKimPJDashRTelmisartan in the diabetic murine model of acute myocardial infarction: dual contrast manganese-enhanced and delayed enhancement MRI evaluation of the peri-infarct regionCardiovasc Diabetol2016152426846539
- PaulisLEGeelenTKuhlmannMTDistribution of lipid-based nanoparticles to infarcted myocardium with potential application for MRI-monitored drug deliveryJ Control Rel20121622276285
- HeXGaoJGambhirSSChengZNear-infrared fluorescent nanoprobes for cancer molecular imaging: status and challengesTrends Mol Med2010161257458320870460
- GongHKovarJLBakerBNear-infrared fluorescence imaging of mammalian cells and xenograft tumors with SNAP-tagPLoS ONE201273e3400322479502
- KhawBADasilvaJHartnerWCCytoskeletal-antigen specific immunoliposome-targeted in vivo preservation of myocardial viabilityJ Control Rel20071201–23540
- WeisSMVascular permeability in cardiovascular disease and cancerCurr Opin Hematol200815324324918391792
- GoldfarbJWArnoldSHanJRecent myocardial infarction: assessment with unenhanced T1-weighted MR imagingRadiology2007245124525017885192
- HeCHuYYinLTangCYinCEffects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticlesBiomaterials201031133657366620138662
- ChenKHLundyDJTohEKNanoparticle distribution during systemic inflammation is size-dependent and organ-specificNanoscale2015738158631587226359216
- DobrovolskaiaMAAggarwalPHallJBMcneilSEPreclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistributionMol Pharm20085448749518510338
- BremerichJSaeedMArhedenHHigginsCBWendlandMFNormal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat modelRadiology2000216252453010924581
- TianXYangFYangCToxicity evaluation of Gd2O3@SiO2 nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivoInt J Nanomed20149140434053
- ChenRLingDZhaoLParallel Comparative Studies on Mouse Toxicity of Oxide Nanoparticle- and Gadolinium-Based T1 MRI Contrast AgentsACS Nano2015912124251243526567968
- SinghSPKumariMKumariSIRahmanMFMahboobMGroverPToxicity assessment of manganese oxide micro and nanoparticles in Wistar rats after 28 days of repeated oral exposureJ Appl Toxicol201333101165117923702825